News for Zoetis Inc. (ZTS)

Zoetis Inc. (NYSE:ZTS) Barclays 27th Annual Global Healthcare March 11, 2025 10:30 AM ETCompany ParticipantsWetteny Joseph - Chief Financial...

Zoetis (ZTS) reachead $170.37 at the closing of the latest trading day, reflecting a +1.87% change compared to its last close.

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going to take a look at where Zoetis Inc.

Zoetis Inc. (NYSE:ZTS) BofA Securities 2025 Animal Health Summit February 27, 2025 1:20 PM ETCompany ParticipantsWetteny Joseph - CFOConference Call...

Zoetis Inc (ZTS) has recently been in the spotlight, drawing interest from investors and financial analysts due to its robust financial stance. With shares curr

Robust product innovation and market leadership in veterinary diagnostics.Expansive global presence with a focus on enhancing veterinary practice efficiency.Ch

Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for medicines in China.

Zoetis Inc (ZTS) announced that it has received a conditional license from the U.S. Department of Agriculture's Center for Veterinary Biologics for its Avian In

Shares of Zoetis Inc (ZTS) fell 3.25% in mid-day trading on Feb 14. The stock reached an intraday low of $157.50, before recovering slightly to $159.58, dow

Zoetis' Q4 earnings met expectations, but the stock fell due to slowing growth and cautious 2025 guidance. Click here to find out why I rate ZTS stock a Buy.

Zoetis Inc. (NYSE:ZTS) Q4 2024 Earnings Conference Call February 13, 2025 8:30 AM ETCompany ParticipantsSteve Frank - IRKristin Peck - CEOWetteny Joseph -...

ZTS stock falls despite better-than-expected fourth-quarter results due to a weak 2025 outlook.

The following slide deck was published by Zoetis Inc.

While the top- and bottom-line numbers for Zoetis (ZTS) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zoetis (ZTS) delivered earnings and revenue surprises of 2.19% and 0.68%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zoetis Inc. (NYSE: ZTS) today reported its financial results for the fourth quarter and full year 2024 as well as provided full year guidance for 2025. The c

Revenue: $2.3 billion for Q4 2024, matching the estimated revenue of $2.3 billion, reflecting a 5% increase year-over-year.Earnings Per Share (EPS): Reported E

On Thursday, February 13, 2025, the stock market exhibited mixed performance as investors grappled with conflicting economic signals and geopolitical

Zoetis (ZTS) Q4 highlights: Non-GAAP EPS beats estimates; revenue grows 5% YoY. 2025 guidance set with 6-8% organic growth.